On August 26, 2019 Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body’s immune system to fight cancer, reported its participation at two upcoming investor conferences in New York City (Press release, Anixa Biosciences, AUG 26, 2019, View Source [SID1234538981]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Management will provide an overview of the company’s business during live presentations and will be available to participate in one-on-one meetings with investors who are registered to attend the conferences.

Details of Anixa’s presentations are as follows:

Event:

Rodman & Renshaw’s 21st Annual Global Investment Conference

Date:

Monday, September 9, 2019

Time:

2:35 p.m. EDT

Location:

Holmes I (4th Floor)

Lotte New York Palace Hotel, New York, NY

Event:

Janney Healthcare Conference

Date:

Tuesday, September 10, 2019

Time:

11:50 a.m. EDT

Location:

Bates Room

The Union League Club, New York, NY

The Rodman & Renshaw conference presentation will be webcast live and remain available for 90 days following the presentation. To access the webcast, please visit the investors section of Anixa’s website at View Source